Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-09

Clinical Trial Update: Colchicine in Postoperative Fontan Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating colchicine in postoperative Fontan patients has been terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: University of Michigan | Conditions: Single-ventricle, Heart Diseases | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2022-05-09